Support Consolidation of Gilead’s Long Range Plan (LRP),and integration across Gilead’s strategic planning processes • Created peer benchmarks on IPR&D reporting across Gileads 12 peers• perform ad hoc analysis, data pull on Hyperion, OBIIE, HRA and SAP

Worked as finance and strategy resource in the Pharmaceutical Development and Manufacturing Function. Gained extensive knowledge of Biopharma manufacturing ecosystem, processes, enabling environment. Evaluated La Verne's Capacity Utilization and process improvement, capabilities on its hydration, fill lines, Spray Dry and Packaging operations and, its upcoming Clinical Flex lines.Got to know Contract Manufacturing Organizations,CMOs and their different business models in the space and understood how they support Gilead's Manufacturing operations. 1. Establish strong business partnerships with Departments to provide comprehensive financial support. 2. Lead financial analysis and assessment to assist business decision making. e.g., San Dimas Decommissioning Project, Power Outage Risk Assessment, Capacity Utilization Assessment.

Worked with top National MFI on strategy review of their agent network model and created new 5-year strategy for next redesign of their mobile-enabled agent network business. Created full 5-year business model with projections across multiple Agent types and transactions types. Business model is significantly complex to accompany the holistic strategy our team recommends for the client to be most competitive in the nascent financial space in Cambodia.As the Consultant, I had chief responsibility for designing the model, managing the team, and managing the client relationship.